Showing results (321-330 of 350) with videos related to

Sort By:
Pageof 35
JAMA Surgery|August 17, 2022
American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive SummaryLinwah Yip, Quan-Yang Duh, Heather Wachtel, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2019
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical CarcinomaVasileios Chortis, Irina Bancos, Thomas Nijman, et al.
The Lancet. Diabetes & Endocrinology|July 7, 2026
Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort studyOnnicha Suntornlohanakul, Giuseppe Reimondo, Marco Ghislieri, et al.
European Journal of Endocrinology|March 6, 2026
Clinical Predictors of Outcome in Advanced Adrenocortical Carcinoma: a multicentre international ENSAT studyAlessandra Mangone, Barbara Altieri, Emanuele Ferrante, et al.
European Journal of Endocrinology|January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasiaLea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
The Lancet. Diabetes & Endocrinology|July 27, 2020
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Angela E Taylor, Vasileios Chortis, et al.
Diabetes Care|June 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone TreatmentRalph A DeFronzo, Vivian Fonseca, Vanita R Aroda, et al.
Diabetes Care|April 18, 2025
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 DiabetesJohn B Buse, Steven E Kahn, Vanita R Aroda, et al.
Ebiomedicine|May 21, 2025
Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasiaNeil R Lawrence, Jeremy Dawson, Zi-Qiang Lang, et al.
Pageof 35